During the past decade, Peter Brojge Lung Cancer Center, Jewish General Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peter Brojge Lung Cancer Center, Jewish General Hospital" #1 collaborator was "Jewish General Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Peter Brojge Lung Cancer Center, Jewish General Hospital" are "Lung Cancer" (2 trials) and "Metastatic NSCLC" (1 trials). Many other conditions were trialed in "Peter Brojge Lung Cancer Center, Jewish General Hospital" in a lesser frequency.

Most popular intervention types in "Peter Brojge Lung Cancer Center, Jewish General Hospital" are "Dietary Supplement" (3 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chinese herbs formula: Shu Yu Wan" (2 trials), "CurcuVIVA™" (1 trials), "Placebo capsules" (1 trials), "Tyrosine Kinase Inhibitor erlotinib (Tarceva)" (1 trials) and "Tyrosine Kinase Inhibitor gefitinib (Iressa)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peter Brojge Lung Cancer Center, Jewish General Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Peter Brojge Lung Cancer Center, Jewish General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Peter Brojge Lung Cancer Center, Jewish General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peter Brojge Lung Cancer Center, Jewish General Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".